-
EP2200626
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2200626
| EP2200626 - ANALOGUES OF EXENDIN-4 AND EXENDIN-3 [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 30.08.2013 Database last updated on 09.09.2024 | Most recent event Tooltip | 30.08.2013 | Application deemed to be withdrawn | published on 02.10.2013 [2013/40] | Applicant(s) | For all designated states IPSEN PHARMA S.A.S. 65, Quai Georges Gorse 92100 Boulogne-Billancourt / FR | [N/P] |
| Former [2010/26] | For all designated states IPSEN PHARMA S.A.S. 65, quai Georges Gorse 91200 Boulogne-Billancourt / FR | Inventor(s) | 01 /
DONG, Zheng, Xin 66 Fairview Street Holliston MA 01746 / US | [2010/26] | Representative(s) | Wells, Andrew, et al HGF Limited 4th Floor, Merchant Exchange 17-19 Whitworth Street West Manchester M1 5WG / GB | [N/P] |
| Former [2010/26] | Wells, Andrew, et al Harrison Goddard Foote 4th Floor, Merchant Exchange 17-19 Whitworth Street West Manchester M1 5WG / GB | Application number, filing date | 08830910.9 | 05.09.2008 | [2010/26] | WO2008US10429 | Priority number, date | US20070967855P | 07.09.2007 Original published format: US 967855 P | [2010/26] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2009035540 | Date: | 19.03.2009 | Language: | EN | [2009/12] | Type: | A2 Application without search report | No.: | EP2200626 | Date: | 30.06.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.03.2009 takes the place of the publication of the European patent application. | [2010/26] | Search report(s) | International search report - published on: | US | 24.09.2009 | (Supplementary) European search report - dispatched on: | EP | 16.01.2012 | Classification | IPC: | A61K38/00, A61K38/27, C07K17/00, C07K14/575, A61K51/08 | [2012/07] | CPC: |
C07K14/57563 (EP,US);
A61P1/14 (EP);
A61P11/00 (EP);
A61P19/02 (EP);
A61P19/10 (EP);
A61P25/00 (EP);
A61P25/28 (EP);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/08 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
|
| Former IPC [2010/26] | A61K38/00, A61K38/27, C07K17/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/26] | Extension states | AL | 31.03.2010 | BA | 31.03.2010 | MK | 31.03.2010 | RS | 31.03.2010 | Title | German: | ANALOGA VON EXENDIN-4 UND EXENDIN-3 | [2010/26] | English: | ANALOGUES OF EXENDIN-4 AND EXENDIN-3 | [2010/26] | French: | ANALOGUES D'EXENDINE-4 ET EXENDINE-3 | [2010/26] | Entry into regional phase | 31.03.2010 | National basic fee paid | 31.03.2010 | Search fee paid | 31.03.2010 | Designation fee(s) paid | 31.03.2010 | Examination fee paid | Examination procedure | 31.03.2010 | Examination requested [2010/26] | 10.08.2012 | Amendment by applicant (claims and/or description) | 27.09.2012 | Despatch of a communication from the examining division (Time limit: M06) | 09.04.2013 | Application deemed to be withdrawn, date of legal effect [2013/40] | 15.05.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/40] | Divisional application(s) | EP13162395.1 / EP2650006 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.09.2012 | Fees paid | Renewal fee | 14.09.2010 | Renewal fee patent year 03 | 29.09.2011 | Renewal fee patent year 04 | 12.09.2012 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]WO9907404 (AMYLIN PHARMACEUTICALS INC [US], et al) [X] 1,7-16 * the whole document * [Y] 1-16; | [XY]WO9925728 (AMYLIN PHARMACEUTICALS INC [US], et al) [X] 1,7-16 * claims 1-4,6-42,45-73 *[Y] 1-16; | [XY]WO0034332 (SOD CONSEILS RECH APPLIC [FR], et al) [X] 1,7-16 * claims 1-6,9-12 * [Y] 1-16; | [XY]WO0034331 (SOD CONSEILS RECH APPLIC [FR], et al) [X] 1,7-16 * claims 1-8,11-14,17,18 * [Y] 1-16; | [XY]WO2006121860 (BAYER PHARMACEUTICALS CORP [US], et al) [X] 1,7-16 * claims 1-3,21,24-30,46-51 * [Y] 1-16 | International search | [Y]US2004092432 (DURING MATTHEW J [US], et al); | [Y]US6767887 (HOFFMANN EIKE [DE], et al); | [Y]US2005159356 (DONG ZHENG X [US], et al); | [Y]US2006293232 (LEVY ODILE E [US], et al); | [Y]US2007042956 (JOHANSEN NILS L [DK], et al) |